Cite
MLA Citation
Francesco Facchinetti et al.. “First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status.” European journal of cancer, vol. 130, 2020, pp. 155–167. http://access.bl.uk/ark:/81055/vdc_100104368168.0x00002a